Molecular markers of circulating melanoma cells.

Abstract excerpt

Of all skin cancers, cutaneous malignant melanoma (CMM) is the most aggressive and the life expectancy of patients with lymphatic or systemic metastases is dramatically reduced. Understandably therefore, scientists and clinicians have focused on improving diagnostic and prognostic techniques. Of these, perhaps the most promising are multimarker real-time RT-PCR and microarray for detection of circulating CMM...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Oncogenes
• Share to Skin Neoplasms
• Share to Antigens, Neoplasm